These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27526329)

  • 1. Insulin Infusion Set Use: European Perspectives and Recommendations.
    Deiss D; Adolfsson P; Alkemade-van Zomeren M; Bolli GB; Charpentier G; Cobelli C; Danne T; Girelli A; Mueller H; Verderese CA; Renard E
    Diabetes Technol Ther; 2016 Sep; 18(9):517-24. PubMed ID: 27526329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future Directions.
    Evert AB; Bode BW; Buckingham BA; Nardacci E; Verderese CA; Wolff-McDonagh P; Walsh J; Hirsch IB
    Diabetes Educ; 2016 Aug; 42(4):470-84. PubMed ID: 27056594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes.
    Cescon M; DeSalvo DJ; Ly TT; Maahs DM; Messer LH; Buckingham BA; Doyle FJ; Dassau E
    J Diabetes Sci Technol; 2016 Nov; 10(6):1268-1276. PubMed ID: 27621142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 7. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.
    Ponder SW; Skyler JS; Kruger DF; Matheson D; Brown BW
    Diabetes Educ; 2008; 34(2):327-33. PubMed ID: 18375782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
    Bally L; Thabit H; Hovorka R
    Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
    [No Abstract]   [Full Text] [Related]  

  • 9. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Insulin Pump Infusion Sets Symposium Report.
    Zhang JY; Shang T; Chattaraj S; Cohen O; Heschel M; Vigersky RA; Heinemann L; Nørgaard K; Svensson J; Buckingham B; Klonoff DC
    J Diabetes Sci Technol; 2021 May; 15(3):705-709. PubMed ID: 33703930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community.
    Hughes MS; Douvas JL; Layfield-Bryan M; Blanco LE; Gray JC; Zapotoczny G; Espinoza J; Wilcox JH; Lal RA
    Diabetes Technol Ther; 2023 Jun; 25(6):426-430. PubMed ID: 36856574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review.
    Zhang G; Romo-Anselmo E; Kwa T; Cohen O; Vigersky R; Chattaraj S
    J Diabetes Sci Technol; 2023 Mar; 17(2):302-313. PubMed ID: 36562593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion.
    Heinemann L; Krinelke L
    J Diabetes Sci Technol; 2012 Jul; 6(4):954-64. PubMed ID: 22920824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical review: insulin pump-associated adverse events in adults and children.
    Ross PL; Milburn J; Reith DM; Wiltshire E; Wheeler BJ
    Acta Diabetol; 2015 Dec; 52(6):1017-24. PubMed ID: 26092321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the hospitalized diabetes patient with an insulin pump.
    McCrea D
    Crit Care Nurs Clin North Am; 2013 Mar; 25(1):111-21. PubMed ID: 23410650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.
    Kovatchev B; Cheng P; Anderson SM; Pinsker JE; Boscari F; Buckingham BA; Doyle FJ; Hood KK; Brown SA; Breton MD; Chernavvsky D; Bevier WC; Bradley PK; Bruttomesso D; Del Favero S; Calore R; Cobelli C; Avogaro A; Ly TT; Shanmugham S; Dassau E; Kollman C; Lum JW; Beck RW
    Diabetes Technol Ther; 2017 Jan; 19(1):18-24. PubMed ID: 27982707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life.
    Freckmann G; Arndt S; Fießelmann A; Klausmann G; Pralle K; Künsting T; Petersen B
    J Diabetes Sci Technol; 2017 Mar; 11(2):253-259. PubMed ID: 27605591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Response to Subcutaneous Infusion Catheter.
    Zhang E; Cao Z
    J Diabetes Sci Technol; 2020 Mar; 14(2):226-232. PubMed ID: 30931603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.